1. Home
  2. LXRX vs FFIC Comparison

LXRX vs FFIC Comparison

Compare LXRX & FFIC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LXRX
  • FFIC
  • Stock Information
  • Founded
  • LXRX 1995
  • FFIC 1929
  • Country
  • LXRX United States
  • FFIC United States
  • Employees
  • LXRX N/A
  • FFIC N/A
  • Industry
  • LXRX Biotechnology: Pharmaceutical Preparations
  • FFIC Major Banks
  • Sector
  • LXRX Health Care
  • FFIC Finance
  • Exchange
  • LXRX Nasdaq
  • FFIC Nasdaq
  • Market Cap
  • LXRX 428.8M
  • FFIC 408.4M
  • IPO Year
  • LXRX 2000
  • FFIC 1995
  • Fundamental
  • Price
  • LXRX $1.13
  • FFIC $14.12
  • Analyst Decision
  • LXRX Buy
  • FFIC
  • Analyst Count
  • LXRX 5
  • FFIC 0
  • Target Price
  • LXRX $3.23
  • FFIC N/A
  • AVG Volume (30 Days)
  • LXRX 1.8M
  • FFIC 187.4K
  • Earning Date
  • LXRX 11-11-2025
  • FFIC 10-23-2025
  • Dividend Yield
  • LXRX N/A
  • FFIC 6.29%
  • EPS Growth
  • LXRX N/A
  • FFIC N/A
  • EPS
  • LXRX N/A
  • FFIC N/A
  • Revenue
  • LXRX $58,432,000.00
  • FFIC $137,137,000.00
  • Revenue This Year
  • LXRX N/A
  • FFIC $113.83
  • Revenue Next Year
  • LXRX N/A
  • FFIC $5.55
  • P/E Ratio
  • LXRX N/A
  • FFIC N/A
  • Revenue Growth
  • LXRX 1504.83
  • FFIC N/A
  • 52 Week Low
  • LXRX $0.28
  • FFIC $10.65
  • 52 Week High
  • LXRX $2.18
  • FFIC $18.59
  • Technical
  • Relative Strength Index (RSI)
  • LXRX 50.83
  • FFIC 71.49
  • Support Level
  • LXRX $1.03
  • FFIC $13.27
  • Resistance Level
  • LXRX $1.15
  • FFIC $14.15
  • Average True Range (ATR)
  • LXRX 0.06
  • FFIC 0.26
  • MACD
  • LXRX -0.01
  • FFIC 0.02
  • Stochastic Oscillator
  • LXRX 50.00
  • FFIC 99.44

About LXRX Lexicon Pharmaceuticals Inc.

Lexicon Pharmaceuticals Inc is a biopharmaceutical company. It is engaged in the discovery, development, and commercialization of pharmaceutical products for the treatment of human diseases. Some of its drug candidates are LX9211, an orally-delivered small molecule drug candidate, also developing LX9851, an orally-delivered small molecule drug candidate, as a treatment for obesity and associated cardiometabolic.

About FFIC Flushing Financial Corporation

Flushing Financial Corp operates as a bank holding company, which is engaged in the provision of banking and financial services. It provides Personal, Business, lending, Government banking, and Card services. Its principal business is attracting retail deposits from the general public and investing those deposits together with funds generated from ongoing operations and borrowings, in originations and purchases of multi-family residential properties, commercial business loans, commercial real estate mortgage loans, construction loans, small business administration loans, and other small business loans.

Share on Social Networks: